Search

GSBS speaker to study neurodegenerative disease - UMass Medical School - Worcester GSBS speaker to study neurodegenerative disease Bryan Goodchild UMass Medical School Communications In this video profile, Graduate School of Biomedical Sciences Class Speaker Jeannette Osterloh explains what her education at UMass Medical School means for her and where she’s headed next. In this video profile, Graduate School of Biomedical Sciences Class Speaker Jeannette Osterloh explains what her education at UMass

Envisioning a cure in rare lung disease - UMass Medical School - Worcester Envisioning a cure in rare lung disease Researchers, families to focus on potential new treatments in Alpha-1 Antitrypsin Deficiency Malorye Branca UMass Medical School Communications Past milestones and future treatment prospects will be described by world-renowned Alpha-1 researchers at a free program at UMMS on Saturday, April 20. Past milestones and future treatment prospects will be described by world-renowned Alpha-1

Spring is here, and with warmer weather comes increased risk for contracting Lyme disease from a deer tick bite. In this Expert’s Corner video, Mark Klempner, MD, discusses the rising incidence of Lyme disease and how individuals can protect themselves.

Two UMass Medical School researchers report on promising new developments in the quest for a treatment for Huntington’s disease in the Thursday, Nov. 1, issue of the New England Journal of Medicine. Neil Aronin, MD, and Melissa J. Moore, PhD, co-authored an editorial on the latest research into Huntington’s disease, an inherited neurological disorder caused by a mutation on a single chromosome.

Three UMMS students traveled to Bolivia for an infectious disease rotation, treating cases considered exotic in the U.S.

Rare genetic disease protects against bipolar disorder Rare genetic disease protects against bipolar disorder UMass Chan researchers uncover genetic pathway that could lead to better treatments Jim Fessenden UMass Medical School Communications A team of scientists led by researchers at the UMass Medical School and the University of Miami Miller School of Medicine have identified what is likely a key genetic pathway underlying bipolar disorder, a breakthrough that could lead to better drugs for treating

UMass Medical School infectious disease expert Mark Klempner gave a State House briefing on the development of a new medicine to protect against Lyme disease.

Mark Klempner, MD, and Richard Ellison, MD, were quoted in a Worcester Telegram & Gazette article on Sunday, April 15, on the prevalence of Lyme disease this spring. They also provided tips to prevent tick bites and an update on the latest research into a vaccine.

A new study involving more than 9,000 Framingham Heart Study participants shows standard electrocardiograms can predict biological age and risk of cardiac disease and death.

Researchers in UMass Chan Medical School’s Center for Microbiome Research are exploring the causal mechanisms by which bacteria in the gut influence chronic illnesses such as Alzheimer’s and Crohn’s disease and in autoimmune disorders and other conditions.